Report Detail
Global and United States Lung Cancer Biomarkers Market Report & Forecast 2022-2028
- RnM4421421 |
- 09 April, 2022 |
- Global |
- 101 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Market Analysis and Insights: Global and United States Lung Cancer Biomarkers Market
This report focuses on global and United States Lung Cancer Biomarkers market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Lung Cancer Biomarkers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Protein Biomarker accounting for % of the Lung Cancer Biomarkers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Diagnostics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Lung Cancer Biomarkers market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Lung Cancer Biomarkers Scope and Market Size
Lung Cancer Biomarkers market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Lung Cancer Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Lung Cancer Biomarkers market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Lung Cancer Biomarkers market is segmented into
Protein Biomarker
Genetic Biomarker
Segment by Application, the Lung Cancer Biomarkers market is segmented into
Diagnostics
Research
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Lung Cancer Biomarkers Market Share Analysis
Lung Cancer Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Lung Cancer Biomarkers business, the date to enter into the Lung Cancer Biomarkers market, Lung Cancer Biomarkers product introduction, recent developments, etc.
The major vendors covered:
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomerieux SA
Merck
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Table of Contents
1 Study Coverage
- 1.1 Lung Cancer Biomarkers Product Introduction
- 1.2 Global Lung Cancer Biomarkers Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Lung Cancer Biomarkers Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Lung Cancer Biomarkers Sales in Volume for the Year 2017-2028
- 1.3 United States Lung Cancer Biomarkers Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Lung Cancer Biomarkers Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Lung Cancer Biomarkers Sales in Volume for the Year 2017-2028
- 1.4 Lung Cancer Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Lung Cancer Biomarkers in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Lung Cancer Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Lung Cancer Biomarkers Market Dynamics
- 1.5.1 Lung Cancer Biomarkers Industry Trends
- 1.5.2 Lung Cancer Biomarkers Market Drivers
- 1.5.3 Lung Cancer Biomarkers Market Challenges
- 1.5.4 Lung Cancer Biomarkers Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Lung Cancer Biomarkers Market Segment by Type
- 2.1.1 Protein Biomarker
- 2.1.2 Genetic Biomarker
- 2.2 Global Lung Cancer Biomarkers Market Size by Type
- 2.2.1 Global Lung Cancer Biomarkers Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Lung Cancer Biomarkers Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Lung Cancer Biomarkers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Lung Cancer Biomarkers Market Size by Type
- 2.3.1 United States Lung Cancer Biomarkers Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Lung Cancer Biomarkers Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Lung Cancer Biomarkers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Lung Cancer Biomarkers Market Segment by Application
- 3.1.1 Diagnostics
- 3.1.2 Research
- 3.1.3 Others
- 3.2 Global Lung Cancer Biomarkers Market Size by Application
- 3.2.1 Global Lung Cancer Biomarkers Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Lung Cancer Biomarkers Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Lung Cancer Biomarkers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Lung Cancer Biomarkers Market Size by Application
- 3.3.1 United States Lung Cancer Biomarkers Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Lung Cancer Biomarkers Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Lung Cancer Biomarkers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Lung Cancer Biomarkers Competitor Landscape by Company
- 4.1 Global Lung Cancer Biomarkers Market Size by Company
- 4.1.1 Top Global Lung Cancer Biomarkers Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Lung Cancer Biomarkers Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Lung Cancer Biomarkers Sales by Manufacturer (2017-2022)
- 4.1.4 Global Lung Cancer Biomarkers Price by Manufacturer (2017-2022)
- 4.2 Global Lung Cancer Biomarkers Concentration Ratio (CR)
- 4.2.1 Lung Cancer Biomarkers Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Lung Cancer Biomarkers in 2021
- 4.2.3 Global Lung Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Lung Cancer Biomarkers Manufacturing Base Distribution, Product Type
- 4.3.1 Global Lung Cancer Biomarkers Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Lung Cancer Biomarkers Product Type
- 4.3.3 Date of International Manufacturers Enter into Lung Cancer Biomarkers Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Lung Cancer Biomarkers Market Size by Company
- 4.5.1 Top Lung Cancer Biomarkers Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Lung Cancer Biomarkers Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Lung Cancer Biomarkers Sales by Players (2020, 2021 & 2022)
5 Global Lung Cancer Biomarkers Market Size by Region
- 5.1 Global Lung Cancer Biomarkers Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Lung Cancer Biomarkers Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Lung Cancer Biomarkers Sales in Volume by Region: 2017-2022
- 5.2.2 Global Lung Cancer Biomarkers Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Lung Cancer Biomarkers Market Size in Value by Region (2017-2028)
- 5.3.1 Global Lung Cancer Biomarkers Sales in Value by Region: 2017-2022
- 5.3.2 Global Lung Cancer Biomarkers Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Lung Cancer Biomarkers Market Size YoY Growth 2017-2028
- 6.1.2 North America Lung Cancer Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Lung Cancer Biomarkers Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Lung Cancer Biomarkers Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Lung Cancer Biomarkers Market Size YoY Growth 2017-2028
- 6.3.2 Europe Lung Cancer Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Lung Cancer Biomarkers Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Lung Cancer Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Lung Cancer Biomarkers Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Lung Cancer Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Bio-Rad Laboratories
- 7.1.1 Bio-Rad Laboratories Corporation Information
- 7.1.2 Bio-Rad Laboratories Description and Business Overview
- 7.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Bio-Rad Laboratories Lung Cancer Biomarkers Products Offered
- 7.1.5 Bio-Rad Laboratories Recent Development
- 7.2 Roche Diagnostics
- 7.2.1 Roche Diagnostics Corporation Information
- 7.2.2 Roche Diagnostics Description and Business Overview
- 7.2.3 Roche Diagnostics Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 Roche Diagnostics Lung Cancer Biomarkers Products Offered
- 7.2.5 Roche Diagnostics Recent Development
- 7.3 Qiagen
- 7.3.1 Qiagen Corporation Information
- 7.3.2 Qiagen Description and Business Overview
- 7.3.3 Qiagen Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 Qiagen Lung Cancer Biomarkers Products Offered
- 7.3.5 Qiagen Recent Development
- 7.4 Illumina
- 7.4.1 Illumina Corporation Information
- 7.4.2 Illumina Description and Business Overview
- 7.4.3 Illumina Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 Illumina Lung Cancer Biomarkers Products Offered
- 7.4.5 Illumina Recent Development
- 7.5 GE Healthcare
- 7.5.1 GE Healthcare Corporation Information
- 7.5.2 GE Healthcare Description and Business Overview
- 7.5.3 GE Healthcare Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 GE Healthcare Lung Cancer Biomarkers Products Offered
- 7.5.5 GE Healthcare Recent Development
- 7.6 Agilent Technologies
- 7.6.1 Agilent Technologies Corporation Information
- 7.6.2 Agilent Technologies Description and Business Overview
- 7.6.3 Agilent Technologies Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Agilent Technologies Lung Cancer Biomarkers Products Offered
- 7.6.5 Agilent Technologies Recent Development
- 7.7 Biomerieux SA
- 7.7.1 Biomerieux SA Corporation Information
- 7.7.2 Biomerieux SA Description and Business Overview
- 7.7.3 Biomerieux SA Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 Biomerieux SA Lung Cancer Biomarkers Products Offered
- 7.7.5 Biomerieux SA Recent Development
- 7.8 Merck
- 7.8.1 Merck Corporation Information
- 7.8.2 Merck Description and Business Overview
- 7.8.3 Merck Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 Merck Lung Cancer Biomarkers Products Offered
- 7.8.5 Merck Recent Development
- 7.9 Abbott Laboratories
- 7.9.1 Abbott Laboratories Corporation Information
- 7.9.2 Abbott Laboratories Description and Business Overview
- 7.9.3 Abbott Laboratories Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 Abbott Laboratories Lung Cancer Biomarkers Products Offered
- 7.9.5 Abbott Laboratories Recent Development
- 7.10 Becton, Dickinson and Company
- 7.10.1 Becton, Dickinson and Company Corporation Information
- 7.10.2 Becton, Dickinson and Company Description and Business Overview
- 7.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 Becton, Dickinson and Company Lung Cancer Biomarkers Products Offered
- 7.10.5 Becton, Dickinson and Company Recent Development
- 7.11 Danaher Corporation
- 7.11.1 Danaher Corporation Corporation Information
- 7.11.2 Danaher Corporation Description and Business Overview
- 7.11.3 Danaher Corporation Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.11.4 Danaher Corporation Lung Cancer Biomarkers Products Offered
- 7.11.5 Danaher Corporation Recent Development
- 7.12 Myriad Genetics
- 7.12.1 Myriad Genetics Corporation Information
- 7.12.2 Myriad Genetics Description and Business Overview
- 7.12.3 Myriad Genetics Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.12.4 Myriad Genetics Products Offered
- 7.12.5 Myriad Genetics Recent Development
- 7.13 Sysmex Corporation
- 7.13.1 Sysmex Corporation Corporation Information
- 7.13.2 Sysmex Corporation Description and Business Overview
- 7.13.3 Sysmex Corporation Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.13.4 Sysmex Corporation Products Offered
- 7.13.5 Sysmex Corporation Recent Development
- 7.14 Hologic
- 7.14.1 Hologic Corporation Information
- 7.14.2 Hologic Description and Business Overview
- 7.14.3 Hologic Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
- 7.14.4 Hologic Products Offered
- 7.14.5 Hologic Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Lung Cancer Biomarkers Industry Chain Analysis
- 8.2 Lung Cancer Biomarkers Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Lung Cancer Biomarkers Distributors
- 8.3 Lung Cancer Biomarkers Production Mode & Process
- 8.4 Lung Cancer Biomarkers Sales and Marketing
- 8.4.1 Lung Cancer Biomarkers Sales Channels
- 8.4.2 Lung Cancer Biomarkers Distributors
- 8.5 Lung Cancer Biomarkers Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Lung Cancer Biomarkers. Industry analysis & Market Report on Lung Cancer Biomarkers is a syndicated market report, published as Global and United States Lung Cancer Biomarkers Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Lung Cancer Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
